News

June 9, 2017

Keytruda Helped Patients with Metastatic Triple-Negative Breast Cancer, Studies Find

Keytruda (pembrolizumab) was effective in treating triple-negative breast cancer regardless of whether women had received previous treatment, according to data presented at the 2017 American Society of Clinical Oncology (ASCO) ... Read more

June 8, 2017

Response to Neratinib and Xeloda Combo Seen in Breast Cancer Patients with Brain Metastasis

News

Combining Puma Biotechnology’s candidate therapy PB272, also known as neratinib, with the chemotherapy drug Xeloda (capecitabine) appears to have therapeutic potential for patients with advanced HER2-positive breast cancer and brain metastasis, who were not previously treated ... Read more

June 7, 2017

Pregnancy Does Not Increase Chances of Breast Cancer Recurrence, Study Finds

News

A retrospective study investigated the safety of pregnancy after breast cancer in young women diagnosed with non-metastatic breast cancer. Data analysis shows that women who become pregnant after breast cancer ... Read more

June 6, 2017June 6, 2017

Lynparza Shrinks Breast Cancer Tumors at Double the Rate of Chemo, Study Shows

News

The ovarian cancer therapy Lynparza (olaparib) shrank the tumors of 60 percent of breast cancer patients treated with it, double the figure for standard chemotherapy, according to a study. Lynparza, a ... Read more

June 5, 2017June 7, 2017

Kisqali, Femara Combo Shows Promise in HR+/HER2- Advanced Breast Cancer Patients

News

The latest results from the Phase 3 MONALEESA-2 study showed that adding Novartis’ Kisqali (ribociclib) to ‎Femara (letrozole) for the treatment of breast cancer in certain postmenopausal women improves the ... Read more

June 2, 2017

Susan G. Komen Launches New Toll-free Clinical Trial Information Helpline for Breast Cancer Patients

News

Susan G. Komen, an organization that fights breast cancer by funding research, screening, education, treatment, and psychosocial support programs, has launched a new toll-free Breast Cancer Clinical Trial Information Helpline ... Read more

June 1, 2017June 1, 2017

Keytruda Shows Meaningful Clinical Benefit When Combined with Standard Therapy for Aggressive Breast Cancer

News

Two independent studies have added new evidence to the benefits of combined therapies with Merck‘s PD-1 inhibitor Keytruda (pembrolizumab) for the treatment of aggressive triple-negative breast cancer (TNBC). Adding Keytruda to standard ... Read more

May 31, 2017

Early-stage Breast Cancer Patients Often Undergo Costly, Unnecessary Post-treatment Testing

News

Researchers found that women who have been treated for early-stage breast cancer and who no longer show symptoms are often advised to undergo advanced imaging and biomarker tests that have been proven ... Read more

May 30, 2017

PMD-026 Reduces Triple Negative Breast Cancer Growth, Mice Study Shows

News

PMD-026 reduced tumor growth in mice with triple negative breast cancer (TNBC), according to its developer, Phoenix Molecular Designs. The therapy, which targets the RSK family of enzymes associated with ... Read more

May 26, 2017May 26, 2017

Even One Alcoholic Drink a Day Enough to Raise Breast Cancer Risk, New Report Warns

News

Just one alcohol-containing beverage a day — less than a standard drink — is sufficient to increase a woman’s risk of breast cancer, according to a new report by ... Read more